Patent details
EP3624837 Title: ANTI-FGFR2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY AGENTS IN CANCER TREATMENT
Basic Information
- Publication number:
- EP3624837
- PCT Application Number:
- US2018032757
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP187305180
- PCT Publication Number:
- WO2018213304
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI-FGFR2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY AGENTS IN CANCER TREATMENT
- French Title of Invention:
- ANTICORPS ANTI-FGFR2 EN COMBINAISON AVEC DES AGENTS CHIMIOTHÉRAPIQUES DANS LE TRAITEMENT DU CANCER
- German Title of Invention:
- ANTI-FGFR2 ANTIKÖRPER IN KOMBINATION MIT CHEMOTHERAPEUTISCHEN MITTELN ZUR BEHANDLUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 15/05/2018
- Grant date:
- 30/07/2025
- EP Publication Date:
- 25/03/2020
- PCT Publication Date:
- 22/11/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/07/2025
- EP B1 Publication Date:
- 30/07/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 15/05/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/07/2025
- Name:
- Five Prime Therapeutics, Inc.
- Address:
- 111 Oyster Point Boulevard, South San Francisco, CA 94080, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 10/09/2025
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- COLLINS, Helen L.
- Address:
- United States (US)
2
- Name:
- ZHANG, Xiang
- Address:
- United States (US)
3
- Name:
- XIANG, Hong
- Address:
- United States (US)
4
- Name:
- HNATYSZYN, James
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201762507053 P
- Priority Date:
- 16/05/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 201762581992 P
- Priority Date:
- 06/11/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/00; A61K 39/395; C07K 16/22; C07K 16/28; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202531
- Publication date:
- 30/07/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202536
- Publication date:
- 03/09/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 01/06/2026
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 09/09/2025 | Power Of Attorney | 1 |
| 10/09/2025 | Outgoing Correspondence | 1 |